During centriole duplication, a single daughter centriole is formed near the mother centriole. The mechanism that determines a single duplication site is unknown. Here, we demonstrate that intrinsic self-organization of Plk4 underlies symmetry breaking in centriole duplication. We show that in its nonphosphorylated state, Plk4 preferentially self-assembles via a disordered linker and that this self-assembly is prevented by autophosphorylation. Consistently, the dissociation dynamics of centriolar Plk4 are controlled by autophosphorylation. We further found that autophophorylated Plk4 is localized as a single focus around the mother centriole before procentriole formation, and is subsequently targeted for STIL-HsSAS6 loading. Perturbing Plk4 self-organization affects the asymmetry of centriolar Plk4 distribution and centriole duplication. We propose that the spatial patterning of Plk4 directs a single duplication site per mother centriole. 
Introduction
The centriole is a nonmembranous organelle that is crucial for centrosome assembly and cilia/flagella formation (1). Centrioles are duplicated once per cell cycle and only a single daughter centriole is formed next to each preexisting mother centriole (2) . To date, proteins that regulate centriole duplication and their protein-protein interactions have been fairly identified (2, 3) . Among these, Polo-like kinase 4 (Plk4) was identified as a master regulator of centriole duplication (4, 5) . Loss of Plk4 or inhibition of its kinase activity results in a failure to assemble procentrioles (4) (5) (6) . In contrast, overexpression of Plk4 induces multiple daughter centriole formation on a single mother centriole (7, 8) . Plk4 phosphorylates STIL, which subsequently promotes STIL-HsSAS6 loading to the assembly site of a newly formed procentriole (9) (10) (11) (12) (13) . In addition, Plk4 autophosphorylates its kinase domain to promote its own kinase activity (14) and that of its degron motif present in a flexible linker (Linker 1, L1) to enhance its own degradation via the SCF(-Trcp) ubiquitin ligase-proteasome pathway (15) (16) (17) (18) . Despite this accumulating information, the mechanism by which the local amount and/or the kinase activity of Plk4 at mother centrioles are coordinated to ensure formation of a "single" daughter centriole on a mother centriole remains elusive.
Results

Autophosphorylation regulates self-assembly of Plk4 in vitro and in cells.
To obtain new insights into the molecular basis of centriole duplication, we investigated the molecular properties of human Plk4. While performing in vitro biochemical experiments, we unexpectedly found that a kinase-dead (KD) mutant of a purified Plk4 fragment (Kinase + Linker 1) was highly insoluble compared with wild-type (WT) (Fig. 1A,1B and S1A). Based on this observation, we speculated that Plk4 may modulate its solubility by autophosphorylation, because Plk4 is known to autophosphorylate its kinase domain and L1 (14, 16, (18) (19) (20) (21) . Recent studies have indicated that protein solubility can be regulated by multiple phosphorylation within the low-complexity region (LCR) (22-24). Because human Plk4 contains an LCR in its disordered L1, we substituted some of the known and putative autophosphorylation sites in or around the LCR with alanine (10A) to generate a nonphosphorylated mutant or with glutamic acid (10E) to generate a phosphomimetic mutant, as described previously (16, 19) (Fig. 1C ). In line with this, the phosphorylation-induced mobility shift of Plk4 WT fragments was largely suppressed by the 10A mutation, suggesting that the target residues in WT fragments were phosphorylated in vitro (Fig. S1B ).
To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig. 1D , S1C and S1D). As expected, the 10A mutant of the Plk4 fragment was mainly detected in the insoluble fraction, unlike the WT. In contrast, incorporation of the 10E mutation in the KD mutant (KD10E) improved the solubility of the Plk4 fragments compared with that of the KD mutant. We also monitored the light scattering of purified GST-Plk4(Kinase+L1)-His6 in solution as an indicator of protein aggregation under thermal control. When the temperature was increased, all the Plk4 fragments increased their light scatter 4 but exhibited the onset of scattering at different temperatures ( Fig. 1E and S1E). Compared with the WT, the KD and 10A mutants started scattering at lower temperatures. Adding the 10E mutation to the KD mutant shifted the onset of scattering to a higher temperature, than that of the KD mutant. In addition, dephosphorylation of the WT fragment by adding -phosphatase (PP) significantly increased the scattering over time (Fig. 1G) , demonstrating that phosphorylation of Plk4 prevents Plk4 aggregation. Furthermore, we confirmed the aggregation properties of Plk4 in vitro using the Proteostat dye, which fluoresces after being incorporated into protein aggregates. Similarly, KD, 10A and PP-treated WT Plk4 fragments showed considerably greater protein aggregation compared with WT and the other mutants ( Fig.   1F and S1F). Because it appeared that the 10A and 10E mutations did not completely mimic the KD and constitutively phosphorylated states of Plk4, respectively, it is possible that phosphorylation at other sites including the degron motif may also cooperatively regulate the solubility of Plk4 proteins. Taken together, we conclude that autophosphorylation of Plk4 regulates not only its protein degradation in cells but also its solubility by modulating its self-aggregating properties (Fig. 1H) .
Recently, it has been shown that biomolecular condensates exhibit macromolecular structures such as spheres, networks and fibrils which are linked to their physiological functions (25, 26) . To characterize Plk4 self-assembly further, we visualized Plk4 fragments (Kinase+L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively. Intriguingly, we found that the KD mutant of GFP-Plk4 fragments (Kinase+L1) forms nano-to micrometer-scale, sphere-like aggregates in vitro, although such structures were barely detectable for the WT in this condition ( Fig. 2A) . This was also true for the full length Plk4 WT and KD (Fig. 2B) .
Interestingly, continuous incubation at 37
o C promoted self-assembly of the 10A mutant of the GFP-Plk4 fragment and further assembly of the KD mutant aggregates ( Fig. 2A ). This 5 observation implies that Plk4 aggregates fuse to form larger aggregates, like protein condensates.
These results demonstrate that in its nonphosphorylated state, Plk4 has an intrinsic ability to self-assemble to form condensate-like aggregates in vitro.
We next asked whether Plk4 also self-assembles in cells. We sought to evaluate solely the properties of Plk4 in cells and to exclude the effect of centrosome components, including those that interact with Plk4, on the behavior of Plk4. To this end, we designed a membrane-tethering system in which Plk4 lacking a CPB domain that binds to Cep152/Cep192
(27) and fused with a CAAX-motif localizes to the plasma membrane ( Fig. 2C and S2A ). When the Plk4 mutant was tethered to the plasma membrane in HeLa cells, known Plk4 interactors were undetectable at the site of the membrane-tethered Plk4 (Fig. S2B) . Therefore, we considered that this system was suitable for specific visualization of Plk4 self-assembly in cells.
Using this system, we found that GFP-Plk4(CPB)-CAAX uniformly localized to the plasma membrane ( Fig.2C and S3 ). In stark contrast, inhibition of the Plk4 kinase activity with centrinone, a specific inhibitor of Plk4, or overexpression of the KD and 10A mutants, significantly induced aggregation of membrane-localized Plk4 (Fig. 2C ). Such aggregation was unlikely to be because of inhibition of autophosphorylation-dependent protein degradation, because inhibition of the degradation pathway by treatment with MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) did not influence the uniform localization of membrane-localized Plk4 (Fig. 2C) . Furthermore, deletion of L1 (L1) suppressed centrinone-induced aggregate formation, suggesting that a disordered L1 domain is required for the aggregation of Plk4 in cells (Fig. 2C) . Overall, we conclude that Plk4 preferentially self-assembles in its nonphosphorylated state both in vitro and in cells.
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Regulated self-assembly mediates changes in centriolar dynamics of Plk4.
What is the significance of Plk4 self-assembly for its localization and function at centrioles? To address this question, we first examined whether self-assembly regulates centriolar Plk4 dynamics by performing fluorescence recovery after photobleaching (FRAP) analysis with
HeLa cells expressing GFP-Plk4. In control cells, overexpressed GFP-Plk4 showed dynamic turnover at centrioles (Fig. 3A) . Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation pathway by MG132 or MLN4924 treatment, significantly impaired the Plk4 turnover at centrioles (Fig. 3A) , although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Fig. 3B ). These data suggest that centriolar Plk4 dynamics are regulated by its kinase activity. In other words, dissociation/diffusion of Plk4 from centrioles seems to be dependent on its kinase activity rather than on local protein degradation. Next, we tested whether introducing nonphosphorylatable mutations to Plk4 affected Plk4 turnover at centrioles (Fig. 3C) . Consistent with the effects of the inhibitor treatment (Fig. 3A) , KD, 10A and 13A mutations, but not a 2A mutation (in the degron motif), attenuated Plk4 turnover at centrioles ( Fig. 3D and S3A ). Together with the in vitro data, these results indicate that the dynamics of Plk4 at centrioles changes depending on autophosphorylation-regulated self-assembly. We speculate that the autophosphorylation-regulated self-assembly properties of Plk4 may be conserved across species, because Drosophila Plk4 (Dm Plk4) exhibited similar behavior in HeLa cells ( Fig. 
S3C-F).
We next asked whether the regulated self-assembly of Plk4 is involved in proper centriole duplication. In human cells, exogenous overexpression of Plk4 under a strong promoter such as CMV (cytomegalovirus) induces centriole overduplication (5, 16) . To express GFP-Plk4 mutants in HeLa cells at levels comparable to endogenous expression, we utilized the 7 endogenous promoter of human Plk4 (28). In this condition, expression of GFP-Plk4 WT resulted in minimal centriole overduplication ( Fig. 3E and S3B ). However, the 2A mutation in the degron motif of Plk4 led to significant centriole overduplication, presumably by increasing Plk4 expression. Importantly, 10A and 13A mutations induced over-duplication of centrioles, to greater extent than the WT and the 2A mutant ( Fig. 3E and S3B ). Although the 10A and 13A mutations may also affect the protein degradation of Plk4 to some extent, these results suggest that to ensure the proper centriole copy number, Plk4 self-assembly must be controlled by autophosphorylation. Overall, we conclude that autophosphorylation of Plk4 promotes not only its degradation but also its dissociation/diffusion dynamics at centrioles by regulating self-assembly and also that this property of Plk4 is critical for proper control of the centriole copy number (Fig. 3F ).
Based on previous knowledge and our current results, we propose a self-organization model comprising two components, phosphorylated and nonphosphorylated-Plk4 species (Fig.   3G ). This study described the mutual interactions of these two components, which are reminiscent of the reaction-diffusion system represented by the Turing model that can be applied to a variety of spatial pattern formation (29, 30) . Similarly, the self-organization model may explain how Plk4 can form spatial patterns at centrioles by means of its dynamic properties including self-assembly and dissociation/diffusion.
Autophosphorylated Plk4 appears as a single focus at mother centrioles prior to STIL-HsSAS6 loading.
Our results thus far raised the possibility that phosphorylated and nonphosphorylated Plk4 may cooperatively regulate their distribution patterns around mother centrioles by self-organization.
Consistent with this concept, we reported that Plk4 forms a biased ring in G1 phase before 8 centriolar loading of STIL-HsSAS6 (9, 31). We first confirmed that in G1 phase, Plk4 formed a ring-like structure with an intense focus ( Fig. 4A and B) . Thereafter, Plk4 changed its localization pattern to a single focus that colocalized with STIL and HsSAS6 in G1/S phase, as reported previously (9, 32) ( Fig. 4A and B) . Next, to monitor autophosphorylation of Plk4 in cells, we newly generated the antibody against phosphorylated serine 305 (pS305) of Plk4 in this study (19, 31) ( To examine whether this spatial pattern of Plk4pS305 is generated through self-organization, we perturbed the putative self-organization system by overexpressing Plk4.
Overexpression of Plk4 interrupted the formation of a single focus of Plk4pS305 and instead induced formation of a uniform ring of Plk4pS305 around mother centrioles in both siControl 9 and siHsSAS6-treated cells (Fig. 4E ). Thus, these results suggest that endogenous expression levels of Plk4 self-organize autophosphorylated Plk4 to a single focus around mother centrioles, which presumably limits STIL-HsSAS6 loading to a single focus (Fig. 4F ).
Autonomous activation of Plk4 drives centriolar loading of STIL-HsSAS6.
Our results demonstrated that Plk4 is autophosphorylated before STIL-HsSAS6 loading, 
Discussion
In this study, we demonstrated that autophosphorylation of Plk4 modulates its self-assembly and dissociation/diffusion dynamics both in vitro and in cells. From these findings, we hypothesize that the intrinsic properties of Plk4 are responsible for its spatial distribution. In our model ( Plk4 is spatially distributed as a single focus around mother centrioles. We thus propose that Plk4 makes a kinase-active focus around the mother centriole through self-organization, which provides the single site for the recruitment of STIL-HsSAS6. Furthermore, given that Plk4 is activated by trans-autophosphorylation depending on its local concentration (14), we assume that increasing amounts of centriolar Plk4 from late mitosis to late G1 phase could be a trigger for autonomous activation (32, 34). In our model, the most important issue to address is how the Plk4 self-organization system generates only one focus of active Plk4 around the mother centriole. To investigate and improve our model further, other approaches such as super-resolution live imaging and mathematical simulation analyses should be applied.
Autophosphorylation of Plk4 triggers its own degradation via the SCF ubiquitin ligase-proteasome pathway (15, 16, 18, 20) . Indeed, we observed that inhibition of SCF ubiquitin ligase or proteasome increased the amount of Plk4 at centrioles. However, our FRAP analysis suggest that centriolar Plk4 dynamics are predominantly regulated by self-assembly via autophosphorylation rather than by protein degradation; i.e., by dissociation of Plk4 from centrioles. Because it is debatable whether ubiquitin-proteasome machineries can directly ubiquitinate and degrade centriolar Plk4 in a PCM-crowded centrosome, we speculate that the degradation machinery may mainly control the cytoplasmic pool of Plk4, whereas the amount of centriolar Plk4 is controlled by autophosphorylation-regulated self-assembly and dissociation.
In addition, we reason that autophosphorylation-dependent dissociation/diffusion of Plk4 from centrioles could increase fidelity by restricting centriole duplication via more rapid delocalization of excess Plk4 from centrioles. In our experiments, the 10A mutation of Plk4 induced centriole overduplication ( Fig. 3E and S3B ). Given that previous studies have suggested that multiple phosphorylation within neighboring regions of the DSG degron somehow enhance Plk4 degradation (16, 20) , it is unclear whether centriole overduplication as a result of the 10A mutation of Plk4 results from defects in degradation of Plk4 or in defects of regulated self-assembly. Because it has been suggested recently that self-aggregation protects the protein from degradation (23), it is possible that degradation of Plk4 is also suppressed by its own aggregation in its nonphosphorylated state. Thus, future investigations are required to distinguish between the effects of autophosphorylation on Plk4 degradation and dissociation/diffusion.
Recent studies have revealed the intrinsically disordered region (IDR) and LCR act in protein condensation (35, 36 Fluorescence intensities were normalized to the "WT, PP(-)". The graph shows mean values and SD of three independent experiments. This experiment was performed at the same time of Figure 1F and the data of PP(-) are the same as Figure 1F . **p<0.01, ns, not significant (Two-tailed t-test). elution buffer (50 mM Tris (pH7.5), 500 mM NaCl, 300 mM Imidazole, 5 mM -mercaptoethanol).
The eluates were dialyzed in dialysis buffer (20 mM Tris (pH7.5), 300 mM or 500 mM NaCl, 1 mM -mercaptoethanol). Protein concentration was determined by Bradford assay.
Spin-down assay
500 M of GST-Plk4(Kinase+L1)-His6 fragments were incubated at 30 o C for 1 hour in kinase buffer (20 mM Tris (pH7.5), 300 mM or 500 mM NaCl, 30 M ATP, 5 mM MgCl2, 1 mM -mercaptoethanol). The protein samples were incubated with GST-tagged PreScission protease at 4 o C, overnight. After the reaction, the samples were centrifuged at 21500 ×g for 10 min and the supernatant was collected as "supernatant fraction". The pellet was once washed with kinase buffer and then resuspended in kinase buffer (same volume as supernatant fraction) as "pellet fraction".
The fractions were analyzed by SDS-PAGE (10% polyacrylamide gel) and CBB staining using SimplyBlue SafeStain (ThermoFisher). Band intensities were measured using Fiji (NIH).
Detection of protein aggregation
To detect the light scattering of protein solution, we used Prometheus NT.48 (NanoTemper technologies). 100 g/ml of GST-His6 and GST-Plk4(Kinase+L1)-His6 fragments in buffer (20 mM Tris (pH7.5), 500 mM NaCl, 30 M ATP, 2.5 mM MgCl2, 1 mM -mercaptoethanol) were loaded into High sensitivity capillaries (NanoTemper technologies). According to the manufacturer's instruction, the samples were subjected to a thermal ramp ( 
RNA interference
The following siRNAs were used: custom siRNA (Sigma Genosys) against 3'UTR of Plk4 Alexa 647-labeled anti-Cep152 (Bethyl laboratories, A302-480A) was generated using Alexa Fluor 647 antibody labeling kit (Molecular probes, A20186) and used for triple staining.
The Plk4pS305 antibody was generated by immunizing a rabbit with a S305-phosphorylated peptide corresponding to amino acids 301-314 (SISGpSLFDKRRLLC) of Plk4 (Eurofins Genomics). The antiserum was subjected to affinity-purification using the phosphorylated peptide and then absorbed non-specific antibodies using non-phosphorylated peptide.
Chemicals
The following chemicals were used; Centrinone (MedChem Express, HY-18682), MG132 (Wako, 135-18453), MLN4924 (Chemscene, CS-0348), Aphidicolin (Sigma, A0781), Lovastatin (Merck, 438185).
Imaging of fluorescence tagged proteins
Fluorescence-labeled protein samples in buffer containing 500 mM NaCl were mounted onto slide glasses (Matsunami, S0318) and covered with cover glasses (Matsunami, C015001). Images of aggregates were taken using Leica TCS SP8 inverted confocal microscope equipped with a Leica HCX PL APO × 63/1.4 oil CS2 objectives and excitation wavelength 488 nm or 561 nm. For imaging of Figure 2C , S2, S3D and S4B, Leica TCS SP8 inverted confocal microscope equipped with a Leica HCX PL APO 63×/NA 1.4 oil CS2 objective was used. The images were collected at 0.4 m z-steps. For Figure 3B , 3E, 4D, 5B-E, S3B, S4C-E, S5C, DeltaVision personal DV-SoftWorx system (Applied Prescision) equipped with a Olympus 60×/NA 1.42 oil objective and a CoolSNAP ES2 CCD camera or EDGE/sCMOS 5.5 camera was used. The images were collected at 0.2 m z-steps. For Figure S5B , Zeiss Axio Imager M2 equipped with a 63×/NA 1.4
Immunostaining and imaging
Plan-APOCHROMAT oil objective and a AxioCam HRm camera was used. The images were collected at 0.25 m z-steps.
3D-SIM analysis in Figure 4 was performed using Nikon N-SIM imaging system equipped with Piezo stage, Apo TIRF 100×/NA 1.49 oil objective, iXon DU-897 EMCCD camera (Andor technology Ltd.) and excitation wave length 488 nm, 561 nm and 640 nm. The images were collected at 0.12 m z-steps. Reconstitution of SIM images was performed using NIS-Element AR software.
Z-projection was performed using Maximum intensity projection using Fiji. The images in Figure   2C , 3B, 3E, 4B-E 5B, 5C, S2B, S3D, S4B, S4C and S5B show the maximum intensity projection and others are a single section.
Quantification analysis
For Fluorescence intensities of centriolar proteins were measured using Fiji by subtracting mean cytoplasmic signal intensity from mean centriolar signal intensity. A defined size of ROI was set for each experiment.
To quantify fluorescence patterns along mother centriole wall in SIM images, "oval profile" analysis in Image J (NIH) was used. Each maximus peak of Plk4pS305 intensity was set to the point of 0 o .
Intensities were normalized to each maximum intensity.
Fluorescence Recovery After Photobleaching (FRAP)
For FRAP analysis, HeLa cells were cultured on 35 mm glass-bottom dishes (Greiner-bio-one, #627870). Before FRAP analysis, the culture medium was changed to DMEM containing 10%FBS without phenol red (Sigma).
FRAP analysis was performed using Leica TCS SP8 inverted confocal microscope equipped with a Leica HCX PL APO × 63/1.4 oil CS2 objectives and a 488 nm laser in a chamber in 5% CO2 at 37 o C.
The pinhole was adjusted at 2.0 airy units. Single section images were recorded at 1.29 sec (pre-bleach) and 5 sec (Fig S3F) or 10 sec (Fig 3A, D) Signal intensity was normalized with the average of three pre-bleach signals. Due to centrosome movements, focus was readjusted during imaging.
Immunoblotting
Protein samples were subjected to SDS-PAGE with 8% polyacrylamide gel and transferred onto
Immobilon-P membrane (Millipore). The membrane was incubated in 5% skim milk in PBS and probed with the primary antibodies in 5% BSA in PBS, followed by incubation with their respective HRP-conjugated secondary antibodies. The membrane was washed in PBS containing 0.02% Tween.
The signal was detected using Amersham ECL Prime Western blotting detection reagent (GE Healthcare) and a Chemi Doc XRC+ (BioRad).
Protein sequence analysis
Intrinsically disordered regions and low-complexity regions were predicted using PrDOS and SMART respectively.
Statistics
Statistical analyses were performed with GraphPad Prism 7.
